KARDIAMEMBRANE
Live / Registered — Registered — Section 8 accepted (as of 25 Feb 2025)
What this means for you
Registered since 07 Aug 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87022847
- Registration number
- 5536261
- Mark type
- Stylized text
- Filed
- 03 May 2016
- Published for opposition
- 18 Oct 2016
- Registered
- 07 Aug 2018
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic products, namely, amniotic patches applied to the skin that are derived from human amnion for implantation and for topical treatment all to promote healing and rejuvenation of wounded bodily tissue; Therapeutic products, namely, amniotic patches applied to internal organs and bodily tissues that are derived from human amnion for implantation and for topical treatment all to promote healing and rejuvenation of wounded bodily tissue
Owner
- Amnio Technology LLC, Phoenix, AZ, US
- Amnio Technology LLC, Phoenix, AZ, US
- Amnio Technology LLC, Phoenix, AZ, US
Prosecution history
- 25 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 25 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 25 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Jun 2024 — TEAS SECTION 8 RECEIVED
- 07 Aug 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Aug 2018 — REGISTERED-PRINCIPAL REGISTER
- 30 Jun 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Jun 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Jun 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jun 2018 — USE AMENDMENT FILED
- 12 Jun 2018 — TEAS STATEMENT OF USE RECEIVED
- 13 Dec 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2017 — SOU EXTENSION 2 GRANTED
- 08 Dec 2017 — SOU EXTENSION 2 FILED
- 12 Dec 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL